Adeno-associated virus and renal tubular-targeted gene transduction

doi:10.3877/cma.j.issn.2095-3216.2021.02.011

Abstract

Abstract:

Renal gene therapy has been studied in recent years, and some progress has been made. The research focus was mainly on adeno-associated virus. This article summarized the research progress of adeno-associated virus in gene transduction, reviewed the different transduction pathways and gene vectors of gene transduction targeting the renal tubules, and discussed the gene transduction strategies and the existing problems in adeno-associated virus gene transduction targeting the renal tubules.

Key words: Adeno-associated virus, Renal tubule, Gene transduction

Qiang Ma, Qiangguo Ao, Yabin Zhang, Qingli Cheng. Adeno-associated virus and renal tubular-targeted gene transduction[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2021, 10(02): 113-116.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2021.02.011

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2021/V10/I02/113

Figures/Tables 2

References 40

[1]	Davis L, Park F. Gene therapy research for kidney diseases [J]. Physiol Genomics, 2019, 51(9): 449-461.
[2]	Isaka Y. Gene therapy targeting kidney diseases: routes and vehicles [J]. Clin Exp Nephrol, 2006, 10(4): 229-235.
[3]	Hanss B, Bruggeman LA. Applications of gene therapy to kidney disease [J]. Curr Opin Nephrol Hypertens, 2003, 12(4): 439-445.
[4]	Fisher KJ, Jooss K, Alston J, et al. Recombinant adeno-associated virus for muscle-directed gene therapy [J]. Nat Med, 1997, 3(3): 306-312.
[5]	Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective [J]. Lancet Respir Med, 2020, 8(1): 65-124.
[6]	Miller DG, Stamatoyannopoulos G. Gene therapy for hemophilia [J]. N Engl J Med, 2001, 344(23): 1782-1784.
[7]	Streck CJ, Dickson PV, Ng CY, et al. Antitumor efficacy of AAV-mediated systemic delivery of interferon-β [J]. Cancer Gene Ther, 2006, 13(1): 99-106.
[8]	Hoyng SA, De Winter F, Gnavi S, et al. Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors [J]. Gene Ther, 2015, 22(10): 767-780.
[9]	Takeda S, Takahashi M, Mizukami H, et al. Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo [J]. Nephron Exp Nephrol, 2004, 96(4): e119-e126.
[10]	Opie SR, Warrington KH, McKenna MA, et al. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding [J]. J Virol, 2003, 77(12): 6995-7006.
[11]	彭建强，谭淑萍，董小岩，等. 2型重组腺相关病毒体外转导培养细胞的研究[J]. 病毒学报，2004, 20(2): 128-132.
[12]	Shao W, Pei X, Cui C, et al. Superior human hepatocyte transduction with adeno-associated virus vector serotype 7 [J]. Gene Ther, 2019, 26(12): 504-514.
[13]	Hanlon KS, Kleinstiver BP, Garcia SP, et al. High levels of AAV vector integration into CRISPR-induced DNA breaks [J]. Nat Commun, 2019, 10(1): 4439.
[14]	Li C, Bowles DE, Dyke T, et al. Adeno-associated virus vectors: potential applications for cancer gene therapy [J]. Cancer Gene Ther, 2005, 12(12): 913-925.
[15]	Chamberlain JR, Schwarze U, Wang PR, et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta [J]. Science, 2004, 303(5661): 1198-1201.
[16]	van Breukelen B, Kanellopoulos PN, Tucker PA, et al. The formation of a flexible DNA-binding protein chain is required for efficient DNA unwinding and adenovirus DNA chain elongation [J]. J Biol Chem, 2000, 275(52): 40897-40903.
[17]	Ginocchio VM, Ferla R, Auricchio A, et al. Current status on clinical development of adeno-associated virus-mediated liver-directed gene therapy for inborn errors of metabolism [J]. Hum Gene Ther, 2019, 30(10): 1204-1210.
[18]	Moullier P, Friedlander G, Calise D, et al. Adenoviral-mediated gene transfer to renal tubular cells in vivo [J]. Kidney Int, 1994, 45(4): 1220-1225.
[19]	Lai LW, Chan DM, Erickson RP, et al. Correction of renal tubular acidosis in carbonic anhydrase ii-deficient mice with gene therapy [J]. J Clin Invest, 1998, 10(7): 1320-1325.
[20]	Lien YH, Lai LW. Liposome-mediated gene transfer into the tubules [J]. Exp Nephrol, 1997, 5(2): 132-136.
[21]	Heikkila P, Parpala T, Lukkarinen O, et al. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system: first steps towards gene therapy of Alport syndrome [J]. Gene Ther, 1996, 3(1): 21-27.
[22]	Rocca CJ, Cherqui S. Gene transfer to mouse kidney in vivo [J]. Methods Mol Biol, 2019, 1937: 227-234.
[23]	Noiri E, Peresleni T, Miller F, et al. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia [J]. J Clin Invest, 1996, 97(10): 2377-2783.
[24]	Haller H, Maasch C, Dragun D, et al. Antisense oligodeoxynucleotide strategies in renal and cardiovascular disease [J]. Kidney Int, 1998, 53(6): 1550-1558.
[25]	Yang B, Ma T, Dong JY, et al. Partial correction of the urinary concentrating defect in aquaporin-1 null mice by adenovirus-mediated gene delivery [J]. Hum Gene Ther, 2000, 11(4): 567-575.
[26]	Cheng QL, Chen XM, Li F, et al. Effects of ICAM-1 antisense oligonucleotide on the tubulointerstitium in mice with unilateral ureteral obstruction [J]. Kidney Int, 2000, 57(1): 183-190.
[27]	Choi YK, Kim YJ, Park HS, et al. Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney [J]. Gene Ther, 2003, 10(7): 559-568.
[28]	Gusella GL, Fedorova E, Hanss B, et al. Lentiviral gene transduction of kidney [J]. Hum Gene Ther, 2002, 13(3): 407-414.
[29]	Hwang J, Singh N, Long C, et al. The lentiviral system construction for highly expressed porcine stearoyl-CoA desaturase-1 and functional characterization in stably transduced porcine swine kidney cells [J]. Lipids, 2018, 53(10): 933-945.
[30]	黄云剑，赵景宏，张憬，等. Smad6和Smad7基因治疗对肾小管间质纤维化进程的影响[J]. 中华肾脏病杂志，2004, 20(5): 358-363.
[31]	Lipkowitz MS, Hanss B, Tulchin N, et al. Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors [J]. J Am Soc Nephrol, 1999, 10(9): 1908-1915.
[32]	Chen S, Agarwal A, Glushakova OY, et al. Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors [J]. J Am Soc Nephrol, 2003, 14(4): 947-958.
[33]	Wang X, Skelley L, Cade R, et al. AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage [J]. Gene Therapy, 2006, 13(14): 1097-1103.
[34]	蔡美顺，于仲元，田松，等. 肾囊药物向肾组织内转运的实验研究[J]. 中华医学杂志，2001, 81(6): 360-363.
[35]	朱虎章，王文洁，黄大伟，等. 肾囊注射甲基泼尼松龙治疗糖尿病肾病的临床研究[J]. 中国中西医结合肾病杂志，2003, 4(7): 412.
[36]	赵慧萍，李欣，甘良英，等. 大鼠肾囊内β-半乳糖苷酶基因注入及其在肾脏内的局部表达[J]. 中国血液净化，2005, 4(6): 322-325, 335.
[37]	Goncalves MA, van der Velde I, Janssen JM, et al. Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors [J]. J Virol, 2002, 76(21): 10734-10744.
[38]	Wang Y, Camp SM, Niwano M, et al. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration [J]. J Viro, 2002, 76(14): 7150-7162.
[39]	McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis [J]. Gene Ther, 2001, 8(16): 1248-1254.
[40]	Chao H, Sun L, Bruce A, et al. Expression of human factor VIII by splicing between dimerized AAV vectors [J]. Mol Ther, 2002, 5(6): 716-722.

Please choose a citation manager

Content to export